Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy

• click to rate

  Posted by Two Blokes Jun 17 - Filed in Stock - 7 views
  
  TEVA teams up with Fosun to speed the development of TEV-56278, a novel anti-cancer immunotherapy targeting PD-1+ T cells.